It's the OTC, rarely on any play out there will you have 100% clear, factual info and that is amplified with R/M plays.
So yes, a little reading between the lines, critical thinking and logic are needed to round out your DD and sentiment.
And yes anything can and does happen, the OTC is all about risk reward, limit risk and maximize reward.
So we have tangible items, we have the merger PR, we have court documents proving Mark has control, that is all factual and provable.
Then we have the tweets showing they seem to have a very conservative, careful approach, one which seems to indicate their intent and professionalism and not one of a normal OTC stock that values hype over substance.
So I take that as they would be forth coming in wanting to separate Ameca from STHC if that were in fact what was happening to avoid any potential associations that could cast Ameca in a negative light especially with the I'm sure frequent emails and such that Mark would be getting, why stay silent furthing the emails when you plan on not having the merger go through, it does not benefit Mark nor Ameca and actually is a negative and potential business risk.
So sure, doesn't mean things are a 100% go, but I think there is enough there to say that Mark Ameca paying for the shell, Mark getting control through the courts and the fact they have not stated it isn't happening leans heavily to everything moving as planned, albeit way behind schedule.
Add in great share structure, no dilution coming or present and a reasonable current market cap leave a nice risk/reward profile
Market Data 
Markets 
AI
